[Clinical experiences with Climen in peri- and postmenopausal women].

Abstract

42 women with signs of androgenization were treated with Climen in the peri- and postmenopause for a period longer than 12 months. The effect on most typical climacteric syndromes was comparable to other free available compounds. Concerning our patients, Climen was more effective than other compounds. In no case the withdrawal of Climen due to side-effects was necessary. Surprisingly an androgenetical loss of hair was stopped in 9 out of 10 cases. Climen widens essentially the therapeutical possibilities concerning hormone replacement in peri- and postmenopausal women and should not only be used in women with signs of androgenization.

• Authors: F Husmann
• Journal: Zentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 119 Issue 3 Pg. 123-7 ( 1997) ISSN: 0044-4197 [Print] Germany
• Vernacular Title: Klinische Erfahrungen mit Climen bei peri- und postmenopausalen Frauen.
• PMID: 9173770 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Drug Combinations
• estradiol valerate, cyproterone acetate drug combination
• Cyproterone Acetate
• Estradiol

Topics

• Adult
• Climacteric (drug effects)
• Cyproterone Acetate (adverse effects, therapeutic use)
• Drug Combinations
• Estradiol (adverse effects, analogs & derivatives, therapeutic use)
• Estrogen Replacement Therapy
• Female
• Humans
• Middle Aged
• Postmenopause (drug effects)
• Premenopause (drug effects)
• Retrospective Studies